ID   NUAK2_HUMAN             Reviewed;         628 AA.
AC   Q9H093;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   15-MAR-2017, entry version 140.
DE   RecName: Full=NUAK family SNF1-like kinase 2;
DE            EC=2.7.11.1;
DE   AltName: Full=Omphalocele kinase 2;
DE   AltName: Full=SNF1/AMP kinase-related kinase;
DE            Short=SNARK;
GN   Name=NUAK2 {ECO:0000312|EMBL:AAH17306.1}; Synonyms=OMPHK2, SNARK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 205-224, FUNCTION,
RP   ENZYME REGULATION, PHOSPHORYLATION AT THR-208, AND MUTAGENESIS OF
RP   THR-208.
RX   PubMed=14976552; DOI=10.1038/sj.emboj.7600110;
RA   Lizcano J.M., Goeransson O., Toth R., Deak M., Morrice N.A.,
RA   Boudeau J., Hawley S.A., Udd L., Maekelae T.P., Hardie D.G.,
RA   Alessi D.R.;
RT   "LKB1 is a master kinase that activates 13 kinases of the AMPK
RT   subfamily, including MARK/PAR-1.";
RL   EMBO J. 23:833-843(2004).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:CAB66825.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis {ECO:0000312|EMBL:CAB66825.1};
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:BAC11234.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Teratocarcinoma {ECO:0000312|EMBL:BAC11234.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4] {ECO:0000312|EMBL:AAH17306.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph {ECO:0000312|EMBL:AAH17306.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=14575707; DOI=10.1016/j.bbrc.2003.09.184;
RA   Suzuki A., Kusakai G., Kishimoto A., Minegichi Y., Ogura T., Esumi H.;
RT   "Induction of cell-cell detachment during glucose starvation through
RT   F-actin conversion by SNARK, the fourth member of the AMP-activated
RT   protein kinase catalytic subunit family.";
RL   Biochem. Biophys. Res. Commun. 311:156-161(2003).
RN   [6] {ECO:0000305}
RP   FUNCTION, AUTOPHOSPHORYLATION, AND MUTAGENESIS OF LYS-81.
RX   PubMed=15345718; DOI=10.1074/jbc.M404334200;
RA   Legembre P., Schickel R., Barnhart B.C., Peter M.E.;
RT   "Identification of SNF1/AMP kinase-related kinase as an NF-kappaB-
RT   regulated anti-apoptotic kinase involved in CD95-induced motility and
RT   invasiveness.";
RL   J. Biol. Chem. 279:46742-46747(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-435; SER-523; SER-544
RP   AND SER-547, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [8]
RP   FUNCTION.
RX   PubMed=19927127; DOI=10.1038/emboj.2009.342;
RA   Humbert N., Navaratnam N., Augert A., Da Costa M., Martien S.,
RA   Wang J., Martinez D., Abbadie C., Carling D., de Launoit Y., Gil J.,
RA   Bernard D.;
RT   "Regulation of ploidy and senescence by the AMPK-related kinase
RT   NUAK1.";
RL   EMBO J. 29:376-386(2010).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [10]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-309; LEU-341; ARG-503; VAL-516 AND
RP   GLU-541.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Stress-activated kinase involved in tolerance to glucose
CC       starvation. Induces cell-cell detachment by increasing F-actin
CC       conversion to G-actin. Expression is induced by CD95 or TNF-alpha,
CC       via NF-kappa-B. Protects cells from CD95-mediated apoptosis and is
CC       required for the increased motility and invasiveness of CD95-
CC       activated tumor cells. Able to phosphorylate 'Ser-464' of LATS1.
CC       {ECO:0000269|PubMed:14575707, ECO:0000269|PubMed:14976552,
CC       ECO:0000269|PubMed:15345718, ECO:0000269|PubMed:19927127}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:14575707, ECO:0000269|PubMed:14976552}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:14575707,
CC         ECO:0000269|PubMed:14976552};
CC   -!- ENZYME REGULATION: Activated by phosphorylation on Thr-208.
CC       {ECO:0000269|PubMed:14976552}.
CC   -!- PTM: Phosphorylated at Thr-208 by STK11/LKB1 in complex with
CC       STE20-related adapter-alpha (STRADA) pseudo kinase and CAB39.
CC       Autophosphorylated in vitro. {ECO:0000269|PubMed:14976552}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. SNF1 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL136891; CAB66825.1; -; mRNA.
DR   EMBL; AK074830; BAC11234.1; -; mRNA.
DR   EMBL; BC017306; AAH17306.1; -; mRNA.
DR   RefSeq; NP_112214.2; NM_030952.2.
DR   UniGene; Hs.497512; -.
DR   ProteinModelPortal; Q9H093; -.
DR   SMR; Q9H093; -.
DR   BioGrid; 123581; 17.
DR   IntAct; Q9H093; 4.
DR   MINT; MINT-4719062; -.
DR   STRING; 9606.ENSP00000356125; -.
DR   BindingDB; Q9H093; -.
DR   ChEMBL; CHEMBL5698; -.
DR   GuidetoPHARMACOLOGY; 2130; -.
DR   iPTMnet; Q9H093; -.
DR   PhosphoSitePlus; Q9H093; -.
DR   BioMuta; NUAK2; -.
DR   DMDM; 74761376; -.
DR   EPD; Q9H093; -.
DR   MaxQB; Q9H093; -.
DR   PaxDb; Q9H093; -.
DR   PeptideAtlas; Q9H093; -.
DR   PRIDE; Q9H093; -.
DR   DNASU; 81788; -.
DR   Ensembl; ENST00000367157; ENSP00000356125; ENSG00000163545.
DR   GeneID; 81788; -.
DR   KEGG; hsa:81788; -.
DR   UCSC; uc001hce.4; human.
DR   CTD; 81788; -.
DR   DisGeNET; 81788; -.
DR   GeneCards; NUAK2; -.
DR   HGNC; HGNC:29558; NUAK2.
DR   HPA; HPA008958; -.
DR   MIM; 608131; gene.
DR   neXtProt; NX_Q9H093; -.
DR   PharmGKB; PA142671243; -.
DR   eggNOG; KOG0611; Eukaryota.
DR   eggNOG; ENOG410XPDM; LUCA.
DR   HOGENOM; HOG000004864; -.
DR   HOVERGEN; HBG007160; -.
DR   InParanoid; Q9H093; -.
DR   KO; K08800; -.
DR   OMA; TDCQEVT; -.
DR   OrthoDB; EOG091G033W; -.
DR   PhylomeDB; Q9H093; -.
DR   TreeFam; TF324572; -.
DR   SignaLink; Q9H093; -.
DR   SIGNOR; Q9H093; -.
DR   GeneWiki; NUAK2; -.
DR   GenomeRNAi; 81788; -.
DR   PRO; PR:Q9H093; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000163545; -.
DR   CleanEx; HS_NUAK2; -.
DR   ExpressionAtlas; Q9H093; baseline and differential.
DR   Genevisible; Q9H093; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0042149; P:cellular response to glucose starvation; IDA:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Apoptosis; ATP-binding; Complete proteome;
KW   Direct protein sequencing; Kinase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    628       NUAK family SNF1-like kinase 2.
FT                                /FTId=PRO_0000247756.
FT   DOMAIN       53    303       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      59     67       ATP. {ECO:0000250|UniProtKB:O60285,
FT                                ECO:0000255|PROSITE-ProRule:PRU00159}.
FT   ACT_SITE    175    175       Proton acceptor.
FT                                {ECO:0000250|UniProtKB:O60285,
FT                                ECO:0000255|PROSITE-ProRule:PRU00159,
FT                                ECO:0000255|PROSITE-ProRule:PRU10027}.
FT   BINDING      81     81       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159,
FT                                ECO:0000269|PubMed:15345718}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     208    208       Phosphothreonine; by LKB1.
FT                                {ECO:0000269|PubMed:14976552}.
FT   MOD_RES     435    435       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     523    523       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     544    544       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     547    547       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     573    573       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BZN4}.
FT   VARIANT     309    309       T -> S (in dbSNP:rs55745939).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040964.
FT   VARIANT     341    341       R -> L (in dbSNP:rs35208615).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040965.
FT   VARIANT     503    503       K -> R (in an ovarian Endometrioid
FT                                carcinoma sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040966.
FT   VARIANT     516    516       A -> V (in dbSNP:rs35070935).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040967.
FT   VARIANT     541    541       G -> E (in a breast pleomorphic lobular
FT                                carcinoma sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040968.
FT   MUTAGEN      81     81       K->R: Loss of autophosphorylation, kinase
FT                                activity and of anti-apoptotic activity.
FT                                {ECO:0000269|PubMed:15345718}.
FT   MUTAGEN     208    208       T->A: Prevents phosphorylation and
FT                                activation by STK11/LKB1 complex.
FT                                {ECO:0000269|PubMed:14976552}.
SQ   SEQUENCE   628 AA;  69612 MW;  F76F8B1BF94F4C87 CRC64;
     MESLVFARRS GPTPSAAELA RPLAEGLIKS PKPLMKKQAV KRHHHKHNLR HRYEFLETLG
     KGTYGKVKKA RESSGRLVAI KSIRKDKIKD EQDLMHIRRE IEIMSSLNHP HIIAIHEVFE
     NSSKIVIVME YASRGDLYDY ISERQQLSER EARHFFRQIV SAVHYCHQNR VVHRDLKLEN
     ILLDANGNIK IADFGLSNLY HQGKFLQTFC GSPLYASPEI VNGKPYTGPE VDSWSLGVLL
     YILVHGTMPF DGHDHKILVK QISNGAYREP PKPSDACGLI RWLLMVNPTR RATLEDVASH
     WWVNWGYATR VGEQEAPHEG GHPGSDSARA SMADWLRRSS RPLLENGAKV CSFFKQHAPG
     GGSTTPGLER QHSLKKSRKE NDMAQSLHSD TADDTAHRPG KSNLKLPKGI LKKKVSASAE
     GVQEDPPELS PIPASPGQAA PLLPKKGILK KPRQRESGYY SSPEPSESGE LLDAGDVFVS
     GDPKEQKPPQ ASGLLLHRKG ILKLNGKFSQ TALELAAPTT FGSLDELAPP RPLARASRPS
     GAVSEDSILS SESFDQLDLP ERLPEPPLRG CVSVDNLTGL EEPPSEGPGS CLRRWRQDPL
     GDSCFSLTDC QEVTATYRQA LRVCSKLT
//
